desipramine has been researched along with ergotamine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Bandyopadhyaya, A; Rajagopalan, DR; Rajagopalan, P; Rajagopalan, R | 1 |
| Cairo-Rawlins, WI; Saxena, PR | 1 |
| Cools, AR; Ellenbroek, BA; Gispen, WH; Spruijt, BM | 1 |
| Ellaway, PH; Pascoe, JE | 1 |
| Wennmalm, A | 1 |
| Arulmani, U; Centurión, D; Sánchez-Lopez, A; Saxena, PR; Vázquez, E; Villalón, CM | 1 |
| Alcántara-Vázquez, O; Centurión, D; Gutiérrez-Lara, EJ; Sánchez-López, A; Villamil-Hernández, MT | 1 |
12 other study(ies) available for desipramine and ergotamine
| Article | Year |
|---|---|
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
The synthesis and comparative receptor binding affinities of novel, isomeric pyridoindolobenzazepine scaffolds.
Topics: Benzodiazepinones; Isomerism; Protein Binding; Protein Structure, Tertiary; Receptors, Cell Surface | 2014 |
Presynaptic inhibition by ergotamine of the responses to cardioaccelerator nerve stimulations in the cat.
Topics: Animals; Cats; Desipramine; Electric Stimulation; Ergotamine; Heart; Heart Rate; Hemodynamics; Spinal Cord; Synapses | 1979 |
Dopaminergic modulation of ACTH-induced grooming.
Topics: Adrenocorticotropic Hormone; Animals; Apomorphine; Catheterization; Desipramine; Ergotamine; Grooming; Haloperidol; Male; Nucleus Accumbens; Oxymetazoline; Periaqueductal Gray; Phentolamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1986 |
Noradrenaline as a transmitter in the spinal cord.
Topics: Animals; Catechols; Chlorpromazine; Cocaine; Desipramine; Electric Stimulation; Electrophysiology; Ergotamine; Methamphetamine; Norepinephrine; Phenoxybenzamine; Rabbits; Spinal Cord; Synaptic Transmission | 1968 |
Studies on mechanisms controlling the secretion of neurotransmitters in the rabbit heart.
Topics: Acetylcholine; Animals; Carbon Isotopes; Catecholamines; Centrifugation, Density Gradient; Chromatography, Ion Exchange; Cocaine; Depression, Chemical; Desipramine; Electric Stimulation; Ergotamine; Female; Ganglionic Blockers; Heart; Hexamethonium Compounds; Hydrogen-Ion Concentration; Male; Myocardium; Nerve Endings; Norepinephrine; Perfusion; Propylamines; Prostaglandins; Rabbits; Spectrophotometry; Stimulation, Chemical; Synaptic Transmission; Time Factors; Tritium; Tyrosine | 1971 |
Pharmacological profile of the 5-HT-induced inhibition of cardioaccelerator sympathetic outflow in pithed rats: correlation with 5-HT1 and putative 5-ht5A/5B receptors.
Topics: Animals; Autonomic Fibers, Preganglionic; Blood Pressure; Decerebrate State; Desipramine; Disease Models, Animal; Drug Therapy, Combination; Electric Stimulation; Ergotamine; Infusions, Intravenous; Injections, Intravenous; Male; Oxadiazoles; Piperazines; Pyridines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sympathetic Nervous System; Tachycardia | 2003 |
Pharmacological evidence that 5-HT1A/1B/1D, α2-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats.
Topics: Animals; Blood Pressure; Desipramine; Ergotamine; Gallamine Triethiodide; Heart Rate; Male; Norepinephrine; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D2; Receptors, Serotonin, 5-HT1; Vasoconstrictor Agents | 2014 |